INTRODUCTION
The central role of arachidonic acid for eicosanoid production in mammalian cells is well documented [1] . Arachidonic acid is also an important membrane component which is required for the maintenance of cellular viability under normal and pathological conditions. The vast majority of the available arachidonic acid is stored in acylated form within membrane phospholipids, and the free acid is released from phospholipid molecules via the hydrolytic action of phospholipase A # (PLA # ). PLA # in mammalian tissues is composed of three distinct enzymes with different primary structures, subcellular localizations and calcium requirements [2] . The first group is commonly known as the secretory (sform) PLA # which has a molecular mass of 14 kDa and requires extracellular (millimolar) concentrations of Ca# + for maximum activation [3] . The s-form of the enzyme does not display any specificity towards the acyl group at the sn-2 position. The second group is commonly known as the cytosolic PLA # (cPLA # ) which has a molecular mass of 85 kDa [4, 5] . The enzyme is located primarily in the cytosol and its activity can be detected at low intracellular (micromolar) Ca# + concentrations. The c-form of the enzyme is activated by phosphorylation followed by the translocation of the phosphorylated enzyme to the membrane in a Ca# + -dependent manner [5] [6] [7] . The enzyme displays a high degree of preference for arachidonoyl groups at the sn-2 position [5, 8] and also possesses lysophospholipase [9, 10] and transacylase activity [11] . The third type of PLA # (h-type) is found exclusively in cardiac tissues, has a molecular mass of 45 kDa, and displays limited selectivity towards specific acyl groups [12] . With the exception of secretory organs, the cytosolic enzyme represents the major type of PLA # for the cellular release of free arachidonic acid.
Abbreviations used : cPLA 2 , cytosolic phospholipase A 2 ; PMA, phorbol 12-myristate 13-acetate ; HELSS, E-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2-H-pyran-2-one ; AACOCF 3 , arachidonoyl trifluoromethane ; DME, Dulbecco's modified Eagle's.
‡ To whom correspondence should be addressed.
resulted in modulation of enzyme activity in a biphasic manner. Pretreatment of cells with phorbol 12-myristate 13-acetate, a known activator of protein kinase C, synergistically potentiated the ionophore-induced arachidonate release in both the control and vitamin E-treated cells. However, vitamin E treatment by itself did not affect the protein kinase C activity, indicating that the vitamin E-induced activation of cPLA # was independent of the protein kinase C cascade. Collectively, these results suggest that vitamin E potentiates arachidonate release through the direct and\or indirect modulation of cPLA # activity.
The naturally occurring form of vitamin E (RRR-α-tocopherol) is a key membrane-bound antioxidant in mammalian cells. It is known as a chain-breaking antioxidant due to its ability to terminate the chain reaction of the lipid peroxidation [13] . Beyond its antioxidative property, vitamin E has been shown to be involved in the regulation of certain enzymes associated with signal transduction processes across biological membranes. For example, Azzi and his group have shown that RRR-α-tocopherol can inhibit protein kinase C and the proliferation of smoothmuscle cells in a manner independent of its antioxidant property [14, 15] . We have recently demonstrated that enrichment of endothelial cells with RRR-α-tocopherol activates diacylglycerol kinase [16] and the CoA-independent acyltransferase [17] .
The role of vitamin E in the regulation of eicosanoid biosynthesis has been well documented [18, 19] . In vitamin E-treated animal models, we and others have reported the reduced formation of thromboxane [20] , 5-hydroxyeicosatetraeinoic acid [21] , and prostaglandin E # [22] in stimulated platelets, neutrophils and macrophages, respectively. Since the release of arachidonate by PLA # is the rate-limiting step in eicosanoid biosynthesis, the inhibition of PLA # activity [23] [24] [25] is generally regarded as the mechanism for the attenuation of eicosanoid production. Alternatively, vitamin E has been shown to stimulate eicosanoid production in some other cell types. For example, the enrichment of cultured endothelial cells with vitamin E caused an increase in arachidonic acid release [26] and prostaglandin I # synthesis [27] . The apparent discrepancy on the action of vitamin E between cell types epitomizes the limitation of each study and illustrates the fragmented nature of our understanding on the role of vitamin E in the regulation of arachidonic acid release in mammalian cells.
The present study is therefore designed to extend our understanding of the role of vitamin E in the regulation of arachidonic acid release and PLA # activity. Using rat heart myoblastic (H9c2) cells as a model, vitamin E was found to potentiate the ionophore-induced release of arachidonic acid. Vitamin E appears to enhance the arachidonic acid release in H9c2 cells via the activation of the cPLA # by both direct and indirect mechanisms. [5,6,8,9,11,12,14,15- 
MATERIALS AND METHODS

Materials
Culture of H9c2 cells
Rat myoblastic H9c2 cells were obtained from the American Type Culture Collection and cultured as described previously [28] . Cells were grown in Dulbecco's modified Eagle's (DME) medium supplemented with 10 % (v\v) heat-inactivated newborn-calf serum, 100 units\ml penicillin G, 100 µg\ml streptomycin and 0.25 µg\ml amphotericin B, at 37 mC in an atmosphere of humidified air\5 % CO # . When the cell cultures reached 80 % confluency, each dish was subcultured at a 1 : 5 ratio. After 4 days of incubation, 80-85 % confluency was obtained. Cells grown in 60-mm-diam. dishes were used for arachidonic acid release experiments, and cells grown in 150-mm-diam. dishes were used for the preparation of subcellular fractions and the subsequent PLA # assay.
Preparation of medium containing vitamin E and radiolabelled arachidonic acid
Vitamin E-enriched medium containing 0.8 µCi\ml of radiolabelled arachidonic acid and 1 % (v\v) newborn-calf serum was prepared as described previously [26] . Aliquots of [5,6,8,9,11, 12,14,15-$H] arachidonic acid (210-217 Ci\mmol) in ethanol were pipetted into sterile plastic tubes and the solvent was evaporated to dryness under N # gas. Appropriate amounts of RRR-α-tocopherol dissolved in DMSO were added to reconstitute the arachidonic acid. Newborn-calf serum was then added to the mixture which was then vortexed vigorously and incubated at 37 mC in the dark for 15 min. DME medium containing antibiotics was added and the mixture was further incubated for 15 min before being added to the culture dishes. The amount of DMSO added was 0.2 % of the final volume. Control medium contained the same amount of DMSO as in the vitamin E-enriched medium.
Cells were incubated with vitamin E and radiolabelled arachidonic acid for 20 h prior to experimental studies.
Calcium ionophore stimulation and measurement of arachidonic acid release
After incubation with radiolabelled arachidonic acid and the indicated concentrations of vitamin E for 20 h, cells were rinsed three times with warm Hepes-buffered saline (pH 7.4) containing 10 mM Hepes, 140 mM NaCl, 4 mM KCl, 5.5 mM glucose, 1.5 mM CaCl # , 1 mM MgCl # and 0.2 % BSA. Cells were stabilized with the buffer for 15 min in a 37 mC incubator and then challenged with calcium ionophore A23187 for 10 min or as otherwise indicated. In some experiments, cells were incubated with PMA for 10 min prior to A2318 stimulation. In other experiments involving cPLA # inhibitors, cells were preincubated with AACOCF $ (1 min) or HELSS (15 min) before stimulation with A23187. After 10 min of stimulation, the incubation solution was collected and acidified with acetic acid. The mixture was centrifuged for 5 min at 800 g and an aliquot was used for lipid extraction by the method of Bligh and Dyer [29] using chloroform\methanol\water (4 : 2 : 3, by vol.). Unlabelled arachidonic acid (50 µg) was added to the extraction mixture as fatty acid carrier. The lower organic phase was collected, the solvent was evaporated to dryness, and the free fatty acid was resolved by TLC with a solvent system consisting of hexane\diethyl ether\acetic acid (70 : 30 : 1, by vol.). The fatty acid band was identified with iodine vapour and its radioactivity was determined by liquid scintillation counting.
Subcellular fractionation
Cells grown in 150-mm-diam. dishes were used for subcellular fractionation. When cell cultures reached approx. 90 % confluency, the cells were rinsed three times with ice-cold PBS and were removed from the dish in the same buffer. The cells were sedimented by centrifugation and then resuspended in 1 ml of buffer A (10 mM Hepes, pH 7.4, 0.25 M sucrose, 1 mM EDTA and 1 mM dithiothreitol). The cell suspension was homogenized with a glass douncer (type A) in an ice-cold water bath for 5 strokes. The cell homogenate was centrifuged for 5 min at 800 g, and the resulting supernatant was centrifuged at 100 000 g for 60 min to obtain the cytosolic and microsomal fractions. The microsomes were suspended in the homogenizing buffer, and an aliquot containing 0.05-0.10 mg of protein from each fraction was used for the PLA # assay.
Determination of PLA 2 activity
Enzyme activity was determined by the release of radiolabelled arachidonic acid from the sn-2 position of 1-stearoyl-2-[1-"%C]arachidonoyl-sn-glycero-3-phosphocholine. The assay mixture contained 50 mM Tris\HCl (pH 8.0), 100 mM NaCl, 1 mg\ml BSA, 5 mM CaCl # , 1 mM dithiothreitol and 2.45 µM 1-stearoyl-2-[1-"%C]arachidonoyl-sn-glycero-3-phosphocholine (60000 d.p.m.\assay) in a final volume of 0.2 ml. The substrate was prepared by evaporating the solvent containing the required amount of 1-stearoyl-2-[1-"%C]arachidonoyl-sn-glycero-3-phosphocholine to dryness under N # gas. The dried phospholipid substrate was resuspended in Tris\HCl buffer containing NaCl, and phosphatidylcholine vesicles were formed by placing the mixture in a water-bath sonicator at 0 mC for 30 min. In experiments that required the presence of vitamin E in the phosphatidylcholine vesicles, a known amount of vitamin E dissolved in ethanol was mixed with the radiolabelled substrate, and the solvent was evaporated prior to sonication with the buffer. The enzyme reaction was initiated by the addition of the enzyme preparation from either the cytosolic or microsomal fraction, and the reaction was allowed to proceed at 37 mC for 30 min. The reaction was quenched by the addition of 1.0 ml of chloroform\ methanol (2 : 1, v\v), followed by 0.05 ml of saturated NaCl and 0.25 ml of water. The radiolabelled arachidonic acid released was separated from the substrate by TLC, and radioactivity was determined by scintillation counting.
Determination of protein kinase C activity
Cells were homogenized in buffer B (50 mM Tris\HCl, pH 7.5, 5 mM EDTA, 10 mM EGTA, 0.25 M sucrose, 0.3 % 2-mercaptoethanol, 10 µM benzamidine, 50 µg\ml PMSF, 10 µg\ml leupeptin, 10 µg\ml aprotinin). The homogenates were centrifuged at 1500 g for 10 min and the resulting supernatant was subjected to centrifugation at 100 000 g for 45 min. The soluble and particulate fractions from the centrifugation were used for subsequent enzyme assays. Protein kinase C activity was determined in an assay system consisting of 4 mM calcium acetate, 2 mol % phosphatidylserine, 6 µg\ml PMA, 225 µM peptide substrate, 7.5 mM dithiothreitol, 35 µM ATP and 11 mM magnesium acetate in a total volume of 75 µl of 50 mM Tris\HCl (pH 7.5) with 0.05 % NaN $ . The reaction, which contained 15-30 µg of proteins from the cytosolic or particulate fractions, was initiated by the addition of 0.2 µCi of [γ-$#P]ATP. After incubation for 15 min at 25 mC, the reaction was terminated by the addition of 100 µl of an acidic quenching reagent. An aliquot of the reaction mixture was spotted on to a piece of peptidebinding paper (RPN77) which was then washed thoroughly with 5 % acetic acid. The radioactivity of $#P-labelled protein bound to the membrane was determined by liquid scintillation counting. The phosphorylation of cellular proteins in the absence of the peptide substrate was subtracted from the data for the calculation of protein kinase C activity.
Immunoblotting analyses
Cells were incubated with the indicated concentrations of vitamin E for 20 h. Samples (50 mg) of protein from each cell lysate were subjected to SDS\7.5 %-PAGE. The protein fractions from the gel were transferred to a nitrocellulose membrane and subsequently allowed to react with a polyclonal anti-cPLA # antibody. The membrane was then exposed to goat anti-(rabbit IgG) antibodies which were coupled with horseradish peroxidase for colour development.
Other analytical procedures
Protein content was determined by the method of Lowry et al. [30] using BSA as standard. Lipid extraction, cell numbers and the quantification of total cellular vitamin E were determined as described previously [26] . Phospholipid fractions were separated from the total lipid extract by TLC with a solvent containing chloroform\methanol\acetic acid\water (85 : 15 : 10 : 3, by vol.). Lipid phosphorus was determined by the method of Rouser et al. [31] . Student's t-test was used for statistical analysis of data.
RESULTS
Vitamin E enhances A23187-induced arachidonic acid release
The presence of vitamin E in the incubation media did not affect the total cellular uptake or incorporation of radiolabelled arachidonate into the major phospholipids and neutral lipids in H9c2 cells (Table 1) . However, when these cells were stimulated with A23187, vitamin E enrichment caused a significant increase in arachidonate release. The data in Figure 1 clearly demonstrate that, irrespective of different times of stimulation or doses of A23187, vitamin E-enriched cells consistently displayed a 2-fold increase in arachidonate release. To demonstrate that the cellular level of vitamin E was elevated during incubation, the vitamin E content, as well as total phospholipid contents, in H9c2 cells was determined. As shown in Table 2 , the endogenous level of vitamin E in H9c2 cells was not detectable. However, a linear relationship was established between the cellular vitamin E content and the concentration of vitamin E (25-100 µM) in the medium after a 20 h incubation. Vitamin E treatment did not affect cell numbers, total protein and phospholipid levels. The ratio of vitamin E to phospholipid was roughly estimated to be 1 : 1450 (0.07 mol %), 1 : 690 (0.15 mol %) and 1 : 350 (0.29 mol %) in cells treated with 25, 50 and 100 µM vitamin E, respectively.
Table 2 Cellular vitamin E and total phospholipid levels in H9c2 cells
Cells were incubated with medium supplemented with 0, 25, 50, 100 µM vitamin E for 20 h. Cellular vitamin E (α-tocopherol) levels were determined by HPLC and total cellular phospholipids were quantified by phosphorus determination as described in the Materials and methods section. Data are expressed as meanspS. 
Vitamin E enhances the activity of PLA 2
To test the hypothesis that the vitamin E-enhanced arachidonate release is mediated by PLA # , the activity of this enzyme was determined in the soluble and particulate fractions of the H9c2 cells enriched with vitamin E. The enzyme activity was assayed in the presence of 5 mM calcium under reducing conditions with -α-1-stearoyl-2-["%C]arachidonoyl-sn-glycero-3-phosphocholine as the substrate. The assay condition was designed to favour the detection of the c-type enzyme. Figure 2 shows that PLA # activity was significantly increased in the soluble fraction of cells incubated with 50 µM or higher vitamin E. In contrast, no significant difference in enzyme activity could be detected in the particulate fraction. Our results indicate that the enhanced arachidonic acid release in H9c2 cells enriched with vitamin E was caused in part by an elevation of the cPLA # activity. To determine the contribution of the s-type (low-molecularmass) enzyme to the total PLA # activity, the cytosol from H9c2 cells was subjected to ultrafiltration by an Amicon Centriflo CF25 membrane system. Over 85 % of the total enzyme activity was retained by the membrane and less than 5 % of the enzyme activity was found in the filtrate. The increase in calcium concentration and\or removal of the reducing conditions in the assay did not significantly increase the enzyme activity in the filtrate. Since the CF25 membrane has a molecular mass cut-off of 25 kDa, our results indicate that the vast majority of the PLA # in the cytosol has a molecular mass larger than 25 kDa, and imply that the c-type form is the principal type of enzyme in the cytosol. In a separate set of experiments, the effects of inhibitors to different types of PLA # were determined. In the presence of 10 µM AACOCF $ , a specific inhibitor of the c-type enzyme [32, 33] , over 70 % of the enzyme activity in the soluble fraction and 50 % of the enzyme activity in the particulate fraction were inhibited (Figure 3 ). In contrast, HELSS, a haloenol lactone known as the ' suicidal ' inhibitor for myocardial PLA # [34] , failed to inhibit the enzyme activity in both fractions (Figure 3 ). When the cytosol was titrated with excess polyclonal anti-cPLA # antibody, at least 75 % of the enzyme activity was inhibited (results not shown). When H9c2 cells were preincubated with AACOCF $ prior to A23187 stimulation, arachidonic acid release was attenuated, and the degree of attenuation was similar between control and vitamin E-treated cells (Table 3) . Pretreatment with Figure 4 Immunoblots of cPLA 2 
from cells treated with different concentrations of vitamin E
Cells were incubated with vitamin E for 20 h. The cell lysates, containing 50 µg of protein, were subjected to SDS/PAGE (7.5 %). The protein bands in the gel were transferred to a nitrocellulose sheet and treated with a polyclonal anti-cPLA 2 antibody. Protein band(s) containing cPLA 2 was detected by a coupled peroxidase colour development system. HELSS had no effect on the rate of arachidonic acid release. Taken together, these results indicate that the vast majority of PLA # activity in H9c2 cells appears to be of the 85 kDa c-type. Our results also support the notion that the increase in arachidonate release was mediated via activation of the cPLA # .
Effect of vitamin E on the c-PLA 2 level measured by immunoblot
The vitamin E-induced enhancement of cPLA # activity could be caused by the modulation of enzyme activity and\or by an increase in enzyme protein. To delineate the mechanism for the elevated PLA # activity, quantitative determination of enzyme proteins was conducted by Western blotting analysis. Cell lysates obtained from the control and vitamin E-treated cells were analysed by SDS\7.5 %-PAGE, after which proteins in the gel were transferred to a cellulose membrane and allowed to react with a polyclonal anti-cPLA # antibody. As shown in Figure 4 , the cPLA # level was 2.3p0.3-fold higher in cells treated with 25-100 µM vitamin E than in the untreated cells. This result clearly shows that vitamin E caused an up-regulation of the enzyme level, which might contribute to the observed increase in enzyme activity.
Direct effect of vitamin E on PLA 2 activity
In addition to the net increase in enzyme protein, the ability of vitamin E to modulate PLA # by direct or indirect mechanisms was also explored. Since vitamin E could not be readily dissolved in the assay mixture, its direct effect on PLA # activity was studied by incorporating this vitamin into the substrate phosphatidylcholine vesicles. As depicted in Figure 5 , the addition of vitamin E into the substrate vesicles directly stimulated enzyme activity in the cytosolic ( Figure 5A ) and particulate ( Figure 5B ) fractions when the vitamin E to phospholipid ratio was below 1 : 250 (0.5 mol %). Maximum stimulation of enzyme activity was observed for both subcellular fractions when the ratio of vitamin E to phospholipid was 1 : 500 (0.2 mol %). However, high vitamin E to phospholipid ratios ( 1 mol %) inhibited PLA # activity. The vitamin E to phospholipid ratios which caused enhancement of enzyme activity appear to be similar to those found in the H9c2 cells during vitamin E incubation ( Table 2) .
Effect of vitamin E and PMA on protein kinase C activity
The indirect effect of vitamin E in modulating PLA # activity was next explored. PMA, a known activator of protein kinase C, has been shown to cause an increase in PLA # activity in stimulated macrophages [35] , glomerular mesangial cells [36] and Chinese hamster ovary cells [37] . Therefore, this agent was employed as 
Table 4 Effect of PMA and vitamin E on A23187-induced arachidonic acid release
Cells were incubated with [
3 H]arachidonic acid in the absence (control) or presence (vitamin E) of 50 µM vitamin E for 20 h. Cells were then stimulated with 10 µM A23187 for 10 min, 100 nM PMA for 10 min, or 100 nM PMA for 10 min followed by 10 µM A23187 for 10 min and the arachidonic acid release was determined. Data are expressed as meanspS. a probe to delineate the mechanism which might involve the indirect activation of PLA # . Table 4 shows that when cells labelled with arachidonate were stimulated with PMA alone, there was no detectable change in the amount of arachidonate release compared with the controls. However, a 2-fold increase in arachidonic acid release was detected when the cells were incubated with PMA for 10 min prior to A2318 stimulation. The vitamin E-induced enhancement of arachidonate release was once again observed in cells treated with A23187 alone. The stimulation of arachidonic acid release by PMA preincubation was reminiscent of the ability of vitamin E to enhance the release of arachidonic acid. To determine whether the actions of PMA and vitamin E were mediated via a common mechanism, the possible effect of protein kinase C in enhancing PLA # activity was explored. The cells were enriched with vitamin E for 20 h, after which time they were incubated with PMA or A23187 for 10 min, and protein kinase C activity was determined in the soluble and particulate fractions. Table 5 shows that in untreated cells, protein kinase C was found mostly in the cytosol. PMA treatment caused a shift of protein kinase C activity from the cytosol to the particulate fraction. In contrast, stimulation of 
DISCUSSION
The central role of arachidonic acid release in the production of eicosanoids in mammalian cells is well documented [1] . Among the different types of PLA # that have been identified thus far, the c-type, which can be up-regulated in response to inflammatory cytokines or various growth factors, is now considered as the key intracellular enzyme which directs arachidonic acid release in stimulated cells [38] . The present study demonstrated this c-type enzyme is regulated by vitamin E in myoblastic H9c2 cells. Since this enzyme also possesses lysophospholipase and transacylase activities [9] [10] [11] and can thus be viewed as a complete enzyme system for the catabolism of membrane phospholipids, the physiological consequence of its activation is expected to lie beyond merely the synthesis of eicosanoids.
The regulation of vitamin E on the particulate PLA # remains undefined. Enzyme activity was not significantly increased in the particulate fractions from cells incubated with vitamin E, but enhancement of enzyme activity was observed when vitamin E was incorporated into substrate vesicles. It is possible that enzyme activity in the particulate fraction was also stimulated by vitamin E, but the presence of endogenous phospholipids would make it difficult to detect such an activation with a labelled exogenous substrate.
Vitamin E appears to modulate the intracellular PLA # activity in H9c2 cells by at least two mechanisms. First, direct incorporation of this vitamin into substrate vesicles was shown to enhance the rate of substrate hydrolysis by cPLA # , with a maximum increase in activity when the molar ratio of vitamin E to phospholipid reached 0.2 mol %. We have shown that this concentration could be achieved through vitamin E supplementation. However, the precise distribution and actual concentration of vitamin E in biomembranes have not been well defined. The possibility of having a very high vitamin E to membrane phospholipid ratio (i.e. 0.5 mol %) which could be inhibitory to the enzyme activity within a particular region of the membrane cannot be ruled out.
Secondly, the modulation of cPLA # level and\or activity by vitamin E was also demonstrated in this study. Cells treated with vitamin E showed a higher PLA # activity which was partly attributed to an elevation of the enzyme protein. However, the change in enzyme protein (about 2-fold) was not commensurate with the increase in enzyme activity (about 30-40 %). The discrepancy could be explained by the recognition of the antibodies to all forms of the enzyme with different degrees of activity. Although the mechanism by which vitamin E elicited a higher amount of enzyme is not known, its action in up-regulating the rate of enzyme synthesis at the transcription or translation level remains a distinct possibility. Indeed, it is becoming increasingly apparent that vitamin E may play a role in the regulation of gene expression through profound effects on the activities of transcription factors NF-κB in Jurkat T cells [39] and AP-1 in smooth-muscle cells [40] . Vitamin E was also found to inhibit monocyte adhesion to endothelial cells by altering the expression of E-selectin on the surface of endothelial cells [41] .
Beyond its ability to increase the protein level of PLA # , vitamin E may modulate the activity of the enzyme in an indirect manner. Numerous studies have suggested that phosphorylation may stimulate PLA # activity by 2-3-fold [5] [6] [7] . In the present study, we have confirmed that cells ' primed ' with PMA prior to A2318 stimulation released more arachidonic acid. However, vitamin E did not alter the protein kinase C activity in cells stimulated with A23187 or PMA. Thus, it appears that the vitamin E-enhanced PLA # activity observed in our study is independent of protein kinase C. Our result is not in agreement with the work of Azzi and his co-workers [14, 15] which showed that protein kinase C activity was inhibited by vitamin E in smooth-muscle cells. This discrepancy can be explained by the cell-specific action of vitamin E which has no effect on protein kinase C activity in other cell types [14] .
In summary, our study clearly shows that vitamin E caused an increase in the cPLA # activity and the subsequent release of arachidonic acid in H9c2 cells. This study also demonstrates the significant role of vitamin E in the regulation of eicosanoid biosynthesis at the level of substrate release during agonist stimulation.
